Physicochemical Properties
| Molecular Formula | C20H16N2O5S |
| Molecular Weight | 396.42 |
| Exact Mass | 396.078 |
| CAS # | 56583-49-4 |
| PubChem CID | 124333 |
| Appearance | Brown to reddish brown solid powder |
| LogP | 4.19 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 28 |
| Complexity | 571 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | MMPTYEXNPWSTOR-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C13H8N2O2.C7H8O3S/c16-13-9-5-1-2-7-11(9)15(17)12(13)10-6-3-4-8-14-10;1-6-2-4-7(5-3-6)11(8,9)10/h1-8H;2-5H,1H3,(H,8,9,10) |
| Chemical Name | 4-methylbenzenesulfonic acid;1-oxido-2-pyridin-2-ylindol-1-ium-3-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | P2Y1 Receptor 0.14 μM μM (IC50) |
| ln Vitro | PIT (0.1–10 μM) has an IC50 value of 0.14 μM and reduces human P2Y1 receptor signaling in a non-competitive and dose-dependent manner[1]. PIT (0.1–10 μM) totally inhibits 2-MeSADP's agonistic activity[1]. PIT (1 nM-10 μM) reduces the buildup of inositol phosphates caused by the agonist 2-MeSADP in a dose-dependent manner[1]. PIT (1 nM–10 μM) inhibits P2Y1 receptor signaling that is triggered by the endogenous agonist ADP in a dose-dependent manner [1]. Higher concentrations (3-100 μM) inhibit ATP-mediated inward current with an IC50 value of 13.2 μM, whereas PIT (0.1-3 μM) increases ATP-responses 2-5 fold[2]. PIT exhibits low affinity for several membrane receptors, such as muscarinic, central benzodiazepine, H1, μ-opioid, dihydropyridine, batrachotoxin, α1, α2-adrenoceptors, 5-HT1A, 5-HT1B, 5-HT2, 5-HT3, D1, D2, and D1[2]. PIT has a pKi value of 5.3 and exhibits affinity to an adenosine (A1) receptor[2]. Irreversibly, PIT (12.5-50 μM) opposes ATP relaxations in guinea pig isolated taenia caeca [2]. |
| ln Vivo | In rats with S-bromo-willardiine injection-induced tonic and tonicoclonic seizures, PIT (10 mg/kg; ip; for 5 days) dramatically protects the white matter and the cortical plate lesions against the insult[3]. |
| References |
[1]. 2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. Biochem Pharmacol. 2004 Jul 15;68(2):231-7. [2]. Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor. Br J Pharmacol. 1996 Mar;117(6):1111-8. [3]. Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2'-pyridylisatogen tosylate and related compounds. Eur J Pharmacol. 2002 May 24;444(1-2):53-60. |
Solubility Data
| Solubility (In Vitro) | DMSO: 83.33 mg/mL (210.21 mM ) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.25 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5226 mL | 12.6129 mL | 25.2258 mL | |
| 5 mM | 0.5045 mL | 2.5226 mL | 5.0452 mL | |
| 10 mM | 0.2523 mL | 1.2613 mL | 2.5226 mL |